JOHN R. LAMONTAGNE MEMORIAL SYMPOSIUM ON PANDEMIC INFLUENZA RESEARCH

April 4-5, 2005

INSTITUTE OF MEDICINE

Day 1- April 4, 2005

8:30

8:45

Welcome and Introduction

Dr. Harvey Fineberg

President, Institute of Medicine

8:45

9:00

Welcome

Honorable Michael O. Leavitt

Secretary, U.S. Department of Health and Human Services

9:00

9:15

Meeting Objectives

Dr. Bruce Gellin

Director, National Vaccine Program Office

9:15

9:45

Current Status of Avian Influenza and Pandemic Threat

Dr. Julie Gerberding

Director, Centers for Disease Control and Prevention

9:45

10:15

Meeting the Challenge of Pandemic Vaccine Preparedness: An FDA Perspective

Dr. Jesse Goodman

Director, Center for Biologics Evaluation and Review

U.S. Food and Drug Administration

10:15

10:45

Global Pandemic Preparedness Research Efforts

Dr. Klaus Stohr

Global Influenza Programme, World Health Organization

10:45

11:00

Discussion

Dr. Harvey Fineberg

11:00

11:30

The Role of NIH Research in Pandemic Influenza Preparedness

Dr. Anthony Fauci

Director, National Institute of Allergy and Infectious Disease, National Institutes of Health

11:30

3:30

Concurrent break-out groups 1-4 (with working lunch)

 

 

 

Group 1 (NAS Room 150):

Influenza Virulence and Antigenic Change

 

 

Group 2 (NAS Board Room):

Controlling Animal Influenza and Decreasing Animal-to-Human Transmission

 

 

Group 3 (NAS Lecture Room):

Influenza Diagnostics for Surveillance

 

 

Group 4 (NAS Members Room):

Treatments and Immunotherapies – Antivirals and Non-Specific Approaches

3:30

5:30

Working group 1,2,3,4 reports to the plenary

Dr. Harvey Fineberg

6:00

9:00

Reception in the Great Hall

 



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement